ArticleInvestigational new drugs2019

Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer.

Yusuke Chihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.